Evidence map›Paper›PMID 38020726›Full record

ArticleBiotechnology reports (Amsterdam, Netherlands)2023

Optimization of the biosynthesis of silver nanoparticles using bacterial extracts and their antimicrobial potential.

Iván Solís-Sandí, Sara Cordero-Fuentes, Reinaldo Pereira-Reyes, José Roberto Vega-Baudrit, Diego Batista-Menezes, Gabriela Montes de Oca-Vásquez

Open access · goldAbstract read
In one paragraph

Article in Biotechnology reports (Amsterdam, Netherlands), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Bioactive Silver Nanoparticles Synthesized Using EndophyticPharmaceuticals (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Biosynthesized Silver Nanoparticles FromInternational journal of microbiology · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Tackling carbapenem-resistantBiotechnology notes (Amsterdam, Netherlands) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Iván Solís-SandíSchool of Biology, Tecnológico de Costa Rica, Campus Central, 159-7050 Cartago, Costa Rica.
Sara Cordero-FuentesSchool of Chemistry, Universidad Nacional, Campus Omar Dengo, 86-3000 Heredia, Costa Rica.
Reinaldo Pereira-ReyesNational Nanotechnology Laboratory, National Center for High Technology, 10109 Pavas, San José, Costa Rica.
José Roberto Vega-BaudritNational Nanotechnology Laboratory, National Center for High Technology, 10109 Pavas, San José, Costa Rica.
Diego Batista-MenezesNational Nanotechnology Laboratory, National Center for High Technology, 10109 Pavas, San José, Costa Rica.
Gabriela Montes de Oca-VásquezNational Nanotechnology Laboratory, National Center for High Technology, 10109 Pavas, San José, Costa Rica.
Centro Nacional de Alta TecnologíaUniversidad Nacional · CRInstituto Tecnológico de Costa Rica · CR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, silver nanoparticles (AgNPs) were biosynthesized using the supernatant and the intracellular extract of

Indexed as

Antimicrobial effectBacterial extractsBiosynthesisCharacterizationSilver nanoparticles

Identifiers

PMID38020726
PMCPMC10643114
OpenAlexW4388160346

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.